Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

07 août 2025 08h00 HE | Source: Route 92 Medical, Inc.

Route 92 Medical Files Patent Infringement Suit Against Balt

Route 92 Medical filed a patent infringement suit against Balt alleging infringement of five U.S. patents protecting its Tenzing delivery technology.
21 mai 2025 08h00 HE | Source: Route 92 Medical, Inc.

Route 92 Medical Announces Results of SUMMIT MAX Clinical Trial Showing Highest First Pass Effect Ever Reported in a Randomized Endovascular Stroke Thrombectomy Study

Route 92 Medical announces results of the SUMMIT MAX randomized clinical trial and receipt of a 510(k) clearance for the HiPoint 88 Reperfusion System.
06 mai 2025 09h00 HE | Source: Route 92 Medical, Inc.

Route 92 Medical Announces Settlement of Patent Litigation with Q’Apel Medical

Route 92 Medical and Q'Apel Medical have settled their patent litigation.
27 mars 2025 08h00 HE | Source: Route 92 Medical, Inc.

Route 92 Medical Receives Australian Therapeutic Goods Administration Approval for its Portfolio of Neurovascular Interventional Products for Treating Patients with Acute Ischemic Stroke

Route 92 Medical receives Australian Therapeutic Goods Administration approval for its portfolio of neurovascular interventional products.
22 juil. 2024 08h00 HE | Source: Route 92 Medical, Inc.

Route 92 Medical Announces Commercial Launch of FreeClimb 88 Catheter System

Route 92 Medical announces the commercial launch of its FreeClimb 88 catheter system.